Literature DB >> 20970834

Expression of monocyte chemotactic protein 3 following simulated birth trauma in a murine model of obesity.

Gino J Vricella1, Mingfang Tao, Cengiz Z Altuntas, Guiming Liu, Michael Kavran, Firouz Daneshgari, Adonis K Hijaz.   

Abstract

OBJECTIVE: To determine the effect of obesity on simulated birth trauma in leptin-deficient obese mice as measured by relative monocyte chemotactic protein 3 (MCP-3) expression.
MATERIALS AND METHODS: A total of 25 wild-type and 25 obese C57BL/6 virgin female mice underwent 1 hour of vaginal distension (VD), sham VD, or anesthesia without VD. Pelvic organ tissues were then harvested either immediately or 24-hours post VD and subsequent real-time polymerase chain reaction analysis was performed.
RESULTS: Urethral MCP-3 levels in wild-type mice were elevated from baseline at 0 hours with a return to baseline at 24 hours in both VD and sham VD groups. In obese mice, there was a 6-fold elevation in MCP-3 levels at 0 hours after sham VD vs control (P <.05), which then returned to baseline levels at 24 hours. After undergoing VD, MCP-3 levels increased to 6-fold baseline values (P = .002) at 0 hours, with continued elevation in MCP-3 levels to 15 times control levels (P = .0003) at 24 hours.
CONCLUSIONS: MCP-3 is significantly over-expressed in the urethral tissues of both wild-type and obese mice immediately after any urethral manipulation. At 24 hours, the MCP-3 expression patterns become divergent between VD and sham VD in obese mice. With a greater degree of trauma, MCP-3 continued to rise at 24 hours, suggesting that the underlying obesity resulted in alterations in response to tissue injury, paralleling the degree of injury. Such associations warrant further investigation into the role of MCP-3 as a chemokine for stem cell migration, with implications for subsequent tissue repair mechanisms after birth trauma.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20970834      PMCID: PMC4169711          DOI: 10.1016/j.urology.2010.07.466

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  22 in total

Review 1.  Stem cells: implications for urology.

Authors:  Kirk C Lo; Shannon Whirledge; Dolores J Lamb
Journal:  Curr Urol Rep       Date:  2005-02       Impact factor: 3.092

2.  Urinary incontinence: prevalence and risk factors at 16 weeks of gestation.

Authors:  K E Højberg; J D Salvig; N A Winsløw; G Lose; N J Secher
Journal:  Br J Obstet Gynaecol       Date:  1999-08

3.  Effect of vaginal distension on blood flow and hypoxia of urogenital organs of the female rat.

Authors:  M S Damaser; C Whitbeck; P Chichester; R M Levin
Journal:  J Appl Physiol (1985)       Date:  2004-12-10

4.  Risk of stress urinary incontinence twelve years after the first pregnancy and delivery.

Authors:  Lars Viktrup; Guri Rortveit; Gunnar Lose
Journal:  Obstet Gynecol       Date:  2006-08       Impact factor: 7.661

5.  Urinary incontinence in US women: a population-based study.

Authors:  Jennifer L Melville; Wayne Katon; Kristin Delaney; Katherine Newton
Journal:  Arch Intern Med       Date:  2005-03-14

6.  Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Heart & Estrogen/Progestin Replacement Study (HERS) Research Group.

Authors:  J S Brown; D Grady; J G Ouslander; A R Herzog; R E Varner; S F Posner
Journal:  Obstet Gynecol       Date:  1999-07       Impact factor: 7.661

7.  Risk factors for urinary incontinence among middle-aged women.

Authors:  Kim N Danforth; Mary K Townsend; Karen Lifford; Gary C Curhan; Neil M Resnick; Francine Grodstein
Journal:  Am J Obstet Gynecol       Date:  2006-02       Impact factor: 8.661

8.  Urinary and anal incontinence in morbidly obese women considering weight loss surgery.

Authors:  Holly E Richter; Kathryn L Burgio; Ronald H Clements; Patricia S Goode; David T Redden; R Edward Varner
Journal:  Obstet Gynecol       Date:  2005-12       Impact factor: 7.661

9.  Prevalence, incidence and correlates of urinary incontinence in healthy, middle-aged women.

Authors:  K L Burgio; K A Matthews; B T Engel
Journal:  J Urol       Date:  1991-11       Impact factor: 7.450

10.  Obstetric practice and the prevalence of urinary incontinence three months after delivery.

Authors:  P D Wilson; R M Herbison; G P Herbison
Journal:  Br J Obstet Gynaecol       Date:  1996-02
View more
  4 in total

1.  Effect of Pregnancy and Delivery on Cytokine Expression in a Mouse Model of Pelvic Organ Prolapse.

Authors:  Bruna M Couri; Andrew T Lenis; Ali Borazjani; Brian M Balog; Mei Kuang; Robert S Butler; Marc S Penn; Margot S Damaser
Journal:  Female Pelvic Med Reconstr Surg       Date:  2017 Nov/Dec       Impact factor: 2.091

Review 2.  Stem cell therapy for voiding and erectile dysfunction.

Authors:  Martin Vaegler; Andrew T Lenis; Lisa Daum; Bastian Amend; Arnulf Stenzl; Patricia Toomey; Markus Renninger; Margot S Damaser; Karl-Dietrich Sievert
Journal:  Nat Rev Urol       Date:  2012-06-19       Impact factor: 14.432

3.  Stem cell homing factor, CCL7, expression in mouse models of stress urinary incontinence.

Authors:  Adonis K Hijaz; Kerry O Grimberg; Mingfang Tao; Brian Schmotzer; Zhina Sadeghi; Yi-Hao Lin; Michael Kavran; Ahmet Ozer; Nan Xiao; Firouz Daneshgari
Journal:  Female Pelvic Med Reconstr Surg       Date:  2013 Nov-Dec       Impact factor: 2.091

4.  Fate of mesoangioblasts in a vaginal birth injury model: influence of the route of administration.

Authors:  Marina Gabriela Monteiro Carvalho Mori da Cunha; Giorgia Giacomazzi; Geertje Callewaert; Lucie Hympanova; Francesca Russo; Greetje Vande Velde; Rik Gijsbers; Maarten Albersen; Maurilio Sampaolesi; Jan Deprest
Journal:  Sci Rep       Date:  2018-07-13       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.